Semi-Annual Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7725436

Concept 2017-04-01 to
2018-03-31
As at
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
11,729,000,000 JPY
19,804,000,000 JPY
Interest and dividends received
405,000,000 JPY
381,000,000 JPY
Interest paid
-24,000,000 JPY
-29,000,000 JPY
Income taxes paid
-1,655,000,000 JPY
-3,769,000,000 JPY
Net cash provided by (used in) operating activities
10,456,000,000 JPY
16,386,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-3,387,000,000 JPY
-2,208,000,000 JPY
Proceeds from sale of property, plant and equipment
91,000,000 JPY
89,000,000 JPY
Purchase of investment securities
-7,099,000,000 JPY
-16,600,000,000 JPY
Other, net
-146,000,000 JPY
-26,000,000 JPY
Net cash provided by (used in) investing activities
-6,038,000,000 JPY
-13,142,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
1,712,000,000 JPY
916,000,000 JPY
Repayments of long-term borrowings
-1,297,000,000 JPY
-1,153,000,000 JPY
Dividends paid
-4,325,000,000 JPY
-4,322,000,000 JPY
Net cash provided by (used in) financing activities
-3,735,000,000 JPY
-5,721,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-210,000,000 JPY
-65,000,000 JPY
Net increase (decrease) in cash and cash equivalents
471,000,000 JPY
-2,543,000,000 JPY
Cash and cash equivalents
42,971,000,000 JPY
42,499,000,000 JPY
45,043,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.